Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 57, 2022. DOI: 10.1590/s2175-97902020000419078. Disponível em: https://www.revistas.usp.br/bjps/article/view/204035.. Acesso em: 18 may. 2024.